FDA approves weight-loss drug Contrave – Boston Globe

Bidness ETCFDA approves weight-loss drug ContraveBoston GlobeBut sales of Vivus's Qsymia and Arena's Belviq have been far below expectations, mostly due to limited insurance coverage. Contrave is approved for people who have a body mass index of 30 or higher, and for those with a BMI of 27 or higher who also …FDA Approves 'Contrave,' New Weight-Loss PillHeadlines & Global Newsall 53 news articles »